24 days ago
BIIB
AnalystsAndrew TsaiAndrew Tsai's Stock Forecasts
AnalystsAndrew Tsai
Analyst Ranking
Bottom 11%
#4538 out of 5069 analysts
Average Return
-3.07%
Win Rate
50%12 out of 24
Risk vs Reward
Poor
Good
Andrew Tsai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Stoke Therapeutics IncSTOK | +153.63% | $13.22 | $33.53 | 2025-07-18 - 2025-10-17 | Strong Buy |
Cerevel Therapeutics Holdings IncCERE | +139.30% | $14.20 | $33.98 | 2020-11-23 - 2021-11-22 | Strong Buy |
Sarepta Therapeutics IncSRPT | +74.77% | $12.88 | $22.51 | 2025-07-24 - 2025-10-17 | Strong Buy |
Xenon Pharmaceuticals IncXENE | +41.19% | $13.11 | $18.51 | 2020-06-01 - 2021-06-01 | Strong Buy |
Intra Cellular Therapies IncITCI | +33.63% | $35.30 | $47.17 | 2021-09-20 - 2022-09-19 | Strong Buy |
Andrew Tsai Analyst Color
Get additional color on Andrew Tsai's coverage of popular stocks
a year ago
SRPT
Andrew Tsai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | 1 | Strong Buy | $300.00 | +57.90% | Maintains | 3 days ago |
Akero Therapeutics IncAKRO | 1 | Hold | $56.00 | +4.01% | Downgrades | 10 days ago |
Biogen IncBIIB | 1 | Strong Buy | $190.00 | +32.87% | Initiates Coverage On | 24 days ago |
Sarepta Therapeutics IncSRPT | 3 | Strong Buy | $35.00 | +55.49% | Maintains | 3 months ago |
Stoke Therapeutics IncSTOK | 1 | Strong Buy | $30.00 | -10.53% | Initiates Coverage On | 3 months ago |
Bridgebio Pharma IncBBIO | 1 | Strong Buy | $70.00 | +27.46% | Initiates Coverage On | 3 months ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $110.00 | +2.89% | Maintains | 4 months ago |
Rocket Pharmaceuticals IncRCKT | 2 | Hold | $2.50 | -32.61% | Downgrades | 5 months ago |
Axsome Therapeutics IncAXSM | 1 | Strong Buy | $200.00 | +56.32% | Initiates Coverage On | 6 months ago |
Ke Holdings IncBEKE | 2 | Strong Buy | $27.00 | +47.78% | Maintains | 7 months ago |
Marinus Pharmaceuticals IncMRNS | 1 | Hold | $0.50 | -9.09% | Downgrades | a year ago |
Relmada Therapeutics IncRLMD | 2 | Strong Buy | $13.00 | N/A | Upgrades | a year ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Fusion Pharmaceuticals IncFUSN | 1 | Hold | $21.00 | N/A | Downgrades | 2 years ago |
Alto Neuroscience IncANRO | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 2 years ago |
Vistagen Therapeutics IncVTGN | 2 | Strong Buy | $15.00 | N/A | Upgrades | 2 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $3.00 | N/A | Initiates Coverage On | 3 years ago |
Athira Pharma IncATHA | 2 | Hold | $30.00 | N/A | Downgrades | 3 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Intra Cellular Therapies IncITCI | 1 | Strong Buy | $70.00 | N/A | Maintains | 4 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 4 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 5 years ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $23.00 | N/A | Assumes | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.